AT-RISK: AuToimmune disorders and cardiovascular RISK.

Back

ESC Professional Premium Access

AT-RISK: AuToimmune disorders and cardiovascular RISK.

Session: Cardiovascular epidemiology & trial design

Topic: Cardiovascular Epidemiology

Speaker: Doctor N. Conrad (Leuven, BE)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Nathalie Conrad

University of Leuven, Leuven (Belgium)

4 presentations

0 follower

5 more presentations in this session

Accuracy of event rate and effect size estimation in major cardiovascular trials

Speaker: Assistant Professor C. Olivier (Freiburg, DE)

Medication adherence assessment and reporting in cardiovascular randomised controlled trials

Speaker: Doctor Z. Ashkir (Oxford, GB)

Long-term effects of coronavirus disease 2019 on the cardiovascular system: the CV COVID-19 registry

Speaker: Doctor V. Arevalos Rivas (Barcelona, ES)

The REALITY project: analysis of a national database with 1.8 million real-life patients to study atherosclerotic cardiovascular disease and familial hypercholesterolemia in Spain.

Speaker: Professor V. Barrios (Madrid, ES)

Development of a risk prediction score and equation for chronic kidney disease: A retrospective cohort study

Speaker: Doctor S. Kawasoe (Kagoshima, JP)

Access

Abstract

Slides

Access the full session

Cardiovascular epidemiology & trial design

Speakers: Doctor N. Conrad, Assistant Professor C. Olivier, Doctor Z. Ashkir, Doctor V. Arevalos Rivas, Professor V. Barrios...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources